Goldman Sachs Group Inc Dexcom Inc Call Options Transaction History

Goldman Sachs Group Inc

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 13, 2024	BUY	$110.31 - $140.45 $1.47 Million - $1.87 Million	13,300 Added 54.96%	37,500 $4.25 Million
Q1 2024 May 15, 2024	SELL	$114.22 - $140.1 $685,320 - $840,600	-6,000 Reduced 19.87%	24,200 $3.36 Million
Q4 2023 Feb 13, 2024	BUY	$75.49 - $124.16 $2.28 Million - $3.75 Million	30,200 New	30,200 $3.75 Million
Q3 2022 May 14, 2024	SELL	$76.35 - $94.18 $1.59 Million - $1.96 Million	-20,800 Reduced 68.87%	9,400 $757,000
Q3 2022 Nov 10, 2022	BUY	$76.35 - $94.18 $717,690 - $885,292	9,400 New	9,400 $757,000

1,019

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $32.6B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.